Naseem Zojwalla Biography and Net Worth

Chief Medical Officer of Olema Pharmaceuticals

Naseem Zojwalla, M.D., joined Olema Oncology as Chief Medical Officer in January 2022, bringing more than 15 years of experience in oncology and clinical development within both the biopharmaceutical industry and academia. Prior to joining Olema, Dr. Zojwalla served as Vice President of Clinical Development at Turning Point Therapeutics and earlier at Peloton Therapeutics (acquired by Merck) where she headed clinical development and strategy leading to the first-in-class approval of Welireg^® (belzutifan) for the treatment of VHL disease.

Earlier in her career, she held roles of increasing responsibility leading clinical programs at multiple oncology-focused companies, including Onyx Pharmaceuticals, ImClone Systems, and Eisai Medical Research. A hematologist/oncologist by training, Dr. Zojwalla was previously an assistant clinical professor of medicine at Columbia University Medical Center. She received her Bachelor of Science degree from Stanford University and her M.D. from Temple University School of Medicine and completed her hematology/oncology fellowship training at Columbia University Medical Center.

What is Naseem Zojwalla's net worth?: The estimated net worth of Naseem Zojwalla is at least $112.24 thousand as of December 23rd, 2025. Dr. Zojwalla owns 4,488 shares of Olema Pharmaceuticals stock worth more than $112,245 as of February 6th. This net worth approximation does not reflect any other assets that Dr. Zojwalla may own. Additionally, Dr. Zojwalla receives a salary of $753,370.00 as Chief Medical Officer at Olema Pharmaceuticals. Learn More about Naseem Zojwalla's net worth.
How old is Naseem Zojwalla?: Dr. Zojwalla is currently 51 years old. There are 4 older executives and no younger executives at Olema Pharmaceuticals. The oldest executive at Olema Pharmaceuticals is Dr. David C. Myles Ph.D., Chief Discovery & Non-Clinical Development Officer, who is 61 years old. Learn More on Naseem Zojwalla's age.
What is Naseem Zojwalla's salary?: As the Chief Medical Officer of Olema Pharmaceuticals, Inc., Dr. Zojwalla earns $753,370.00 per year. There are 2 executives that earn more than Dr. Zojwalla. The highest earning executive at Olema Pharmaceuticals is Dr. Sean P. Bohen M.D., Ph.D., President, CEO & Director, who commands a salary of $1,150,000.00 per year. Learn More on Naseem Zojwalla's salary.
How do I contact Naseem Zojwalla?: The corporate mailing address for Dr. Zojwalla and other Olema Pharmaceuticals executives is 512 2ND STREET 4TH FLOOR, SAN FRANCISCO CA, 94107. Olema Pharmaceuticals can also be reached via phone at 650-243-5555 and via email at [email protected]. Learn More on Naseem Zojwalla's contact information.
Has Naseem Zojwalla been buying or selling shares of Olema Pharmaceuticals?: Naseem Zojwalla has not been actively trading shares of Olema Pharmaceuticals during the last quarter. Most recently, Naseem Zojwalla sold 99,509 shares of the business's stock in a transaction on Tuesday, December 23rd. The shares were sold at an average price of $27.66, for a transaction totalling $2,752,418.94. Following the completion of the sale, the insider now directly owns 4,488 shares of the company's stock, valued at $124,138.08. Learn More on Naseem Zojwalla's trading history.
Who are Olema Pharmaceuticals' active insiders?: Olema Pharmaceuticals' insider roster includes Sean Bohen (CEO), Ian Clark (Director), Cyrus Harmon (CTO), Kinney Horn (Insider), William Kovacs (Insider), David Myles (Chief Discovery and Non-Clinical Development Officer), and Naseem Zojwalla (Chief Medical Officer). Learn More on Olema Pharmaceuticals' active insiders.
Are insiders buying or selling shares of Olema Pharmaceuticals?: During the last twelve months, insiders at the sold shares 16 times. They sold a total of 790,501 shares worth more than $22,257,272.41. The most recent insider tranaction occured on January, 20th when Director Cyrus Harmon sold 10,000 shares worth more than $268,800.00. Insiders at Olema Pharmaceuticals own 16.4% of the company. Learn More about insider trades at Olema Pharmaceuticals.
Information on this page was last updated on 1/20/2026.

Naseem Zojwalla Insider Trading History at Olema Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/23/2025	Sell	99,509	$27.66	$2,752,418.94	4,488
12/22/2025	Sell	100,000	$28.04	$2,804,000.00	53,997
12/19/2025	Sell	70,000	$28.20	$1,974,000.00	103,997
11/21/2023	Sell	7,461	$14.84	$110,721.24	37,759

Naseem Zojwalla Buying and Selling Activity at Olema Pharmaceuticals

Olema Pharmaceuticals Company Overview

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 3 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer; and OP-1250 combine with CDK4/6 inhibitors palbociclib, ribociclib, and alpelisib in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive human epidermal growth factor receptor 2-negative breast cancer, as well as develops OPERA-01 for the of ER+/HER2- advanced or metastatic breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

Today's Range

Now: $26.08

$25.46

$26.48

50 Day Range

MA: $27.49

$24.57

$35.83

2 Week Range

Now: $26.08

$2.86

$36.26

Volume

262,867 shs

Average Volume

1,294,706 shs

Market Capitalization

$1.79 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.89

Naseem Zojwalla Biography and Net Worth

What is Naseem Zojwalla's net worth?

How old is Naseem Zojwalla?

What is Naseem Zojwalla's salary?

How do I contact Naseem Zojwalla?

Has Naseem Zojwalla been buying or selling shares of Olema Pharmaceuticals?

Who are Olema Pharmaceuticals' active insiders?

Are insiders buying or selling shares of Olema Pharmaceuticals?